All episodes

Ep. 122: News on the risk of malformations and developmental impairment among the offspring of female patients under antiseizure medication

Ep. 122: News on the risk of malformations and developmental impairment among the offspring of female patients under antiseizure medication

18m 13s

Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)

Guest: Jakob Christensen (Aarhus, Denmark)
This week Bernhard Steinhoff talks with Jakob Christensen about the latest news on the risk of antiseizure medications in pregnancy and beyond. They mention new data on teratogenicity and the increased probability of autism spectrum disorders and cognitive impairment of the offspring.

Ep. 121: New developments concerning neurostimulation in epilepsy​

Ep. 121: New developments concerning neurostimulation in epilepsy​

21m 26s

Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)
Guest: Kristl Vonck (Gent, Belgium)
In this episode, Bernhard Steinhoff speaks with expert Kristl Vonck on the latest advancements in neurostimulation therapies for epilepsy. They explore how innovations in vagus nerve and deep brain stimulation are enhancing personalized treatment approaches, offering new hope for epilepsy patients resistant to traditional therapies.

Ep. 120: New developments of long- and ultralong EEG in epileptology​

Ep. 120: New developments of long- and ultralong EEG in epileptology​

20m 12s

Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)
Guest: Andreas Schulze-Bonhage (Freiburg, Germany)

In this episode Bernhard J. Steinhoff and Andreas Schulze-Bonhage discuss the new fascinating perspectives and possibilities of EEG technologies that allow high-class long and ultra-long recordings. Schulze-Bonhage shares these new developments of a method still uniquely important for epileptologists.

Ep. 119: Phase 2 HOPE clinical trial results

Ep. 119: Phase 2 HOPE clinical trial results

23m 46s

Moderator: Theodoros M. Mavridis (Dublin, Ireland)
Guest: Messoud Ashina (Glostrup, Denmark)

In this episode Theodoros M. Mavridis and Messoud Ashina delve into the findings of the Phase 2 HOPE clinical trial, which assesses the efficacy and safety of Lu AG09222, a monoclonal antibody that targets the PACAP pathway. They explore the potential of this innovative treatment for migraine prevention while highlighting the critical role of the PACAP pathway in migraine pathophysiology.

Ep. 118: Rare causes of myelopathy

Ep. 118: Rare causes of myelopathy

23m 49s

Moderator: Roland Wiest (Bern, Switzerland)
Guest: Randolf Klingebiel (Bielefeld, Germany)

In this episode, Roland Wiest and Randolf Klingebiel explore rare causes of myelopathy, a challenging condition due to its infrequent occurrence and diverse origins. They discuss the diagnostic workup, imaging protocols, and differential diagnoses, emphasizing the importance of collaboration between neurologists and neuroradiologists in managing these complex cases.

Ep. 117: Imaging of spinal cord ischemia

Ep. 117: Imaging of spinal cord ischemia

22m 57s

Moderator: Raphael Wurm (Vienna, Austria)
Guest: Majda Thurnher (Vienna, Austria)

For this episode, Raphaela Wurm welcomes Majda Thurnher to dive into the challenges and joys of diagnosing spinal cord ischemia as they explore MRI protocols, key imaging findings, and the impact of diffusion-weighted imaging.

Ep. 116: ​Indications and pitfalls of spinal imaging​

Ep. 116: ​Indications and pitfalls of spinal imaging​

22m 31s

Moderator: Raphael Wurm (Vienna, Austria)
Guest: Dr. Wolfgang Marik (Vienna, Austria)

In this episode, Raphael Wurm and Wolfgang Marik explore key neuroimaging techniques for the spine, focusing on when to use CT, MRI, myelography, and spinal arteriography. They discuss how to choose the right technology and address common challenges that can be avoided with proper indications.

Ep. 115: Can we prevent dementia?

Ep. 115: Can we prevent dementia?

21m 35s

EAN moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Sebastiaan Engelborghs (Brussel, Belgium)

In this episode Youssuf Saleh and Sebastiaan Engelborghs discuss dementia prevention, with particular reference to the recently published lancet commission report on dementia prevention, intervention and care. Key areas of discussion include what those risks are, how they can be mitigated and what adaptations the field of neurology and public health need to minimise the burden of dementia in aging populations.

Ep. 114: Neurological Prognosis and Treatment after Cardiac Arrest

Ep. 114: Neurological Prognosis and Treatment after Cardiac Arrest

28m 33s

EAN moderator: Marian Galovic (Zurich, Switzerland)

Guest: Michel van Putten (Enschede, The Netherlands)
In this episode, Marian Galovic talks with Prof. Michel van Putten about the effects of cardiac arrest on the brain. They highlight the role of EEG in assessing long-term prognosis following cardiac arrest and discuss the treatment of rhythmic or periodic EEG patterns.